IRIS - Res&Arch Institutional Research Information System - Research & Archive

FANELLI, Carmine Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.619
EU - Europa 2.964
AS - Asia 1.007
OC - Oceania 17
AF - Africa 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.607
IE - Irlanda 592
UA - Ucraina 575
SE - Svezia 504
SG - Singapore 469
IT - Italia 454
HK - Hong Kong 205
DE - Germania 188
FI - Finlandia 184
CN - Cina 172
RU - Federazione Russa 143
FR - Francia 109
VN - Vietnam 86
GB - Regno Unito 81
TR - Turchia 30
AT - Austria 25
CH - Svizzera 20
CZ - Repubblica Ceca 16
NL - Olanda 16
AU - Australia 14
GR - Grecia 12
PL - Polonia 11
BE - Belgio 10
UZ - Uzbekistan 9
KR - Corea 8
ES - Italia 7
CA - Canada 6
RO - Romania 6
LB - Libano 5
MX - Messico 5
BR - Brasile 4
ID - Indonesia 4
IN - India 4
JP - Giappone 4
AR - Argentina 3
EE - Estonia 3
EU - Europa 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
ZA - Sudafrica 3
BW - Botswana 2
DK - Danimarca 2
EG - Egitto 2
IM - Isola di Man 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
Totale 7.626
Salva come PNG Salva come JPEG
Città #
Chandler 684
Dublin 592
Singapore 372
San Mateo 346
Boardman 276
Jacksonville 269
Hong Kong 203
Altamura 192
Santa Clara 182
Medford 171
Princeton 169
Wilmington 144
Lawrence 129
Perugia 104
Ann Arbor 88
Des Moines 86
Dong Ket 85
Andover 78
Helsinki 57
Beijing 54
Saint Petersburg 53
Falls Church 35
Munich 34
Ashburn 33
New York 33
Izmir 28
Rome 27
Woodbridge 27
Norwalk 25
Los Angeles 23
Fremont 16
Amelia 15
San Paolo di Civitate 15
Redmond 14
Dallas 13
Moscow 13
Brno 11
Auburn Hills 10
Brussels 10
Vienna 10
Shanghai 8
Cáceres 7
Redwood City 7
Den Haag 6
Frankfurt Am Main 6
Frankfurt am Main 6
Houston 6
Melbourne 6
Renton 6
San Diego 6
Seoul 6
Athens 5
Bucu 5
Rotterdam 5
Terni 5
Bologna 4
Cardiff 4
Chicago 4
Collazzone 4
Columbia 4
Lappeenranta 4
Lausanne 4
Olomouc 4
Salerno 4
Sinalunga 4
Amsterdam 3
Bolton 3
Corridonia 3
Durban 3
Kaohsiung 3
London 3
Spoleto 3
Surrey 3
Tallinn 3
Tappahannock 3
Antrim 2
Arezzo 2
Auckland 2
Bari 2
Catania 2
Douglas 2
Fairfield 2
Gaborone 2
Grandate 2
Hamburg 2
Hyderabad 2
Istanbul 2
Jakarta 2
Jose C. Paz 2
Lambeth 2
Leipzig 2
León 2
Magelang 2
Manassas 2
Marseille 2
Minya 2
Nanjing 2
Nürnberg 2
Osoppo 2
Perth 2
Totale 4.936
Salva come PNG Salva come JPEG
Nome #
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 117
Adrenaline vs glucagon in the primacy of glucose counterregulation 104
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 102
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 97
Hypoglycemia 93
An intensive lifestyle intervention in children with attention-deficit/hyperactivity disorder 92
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes 86
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 84
IMPACT OF NOCTURNAL HYPOGLYCEMIA ON HYPOGLYCEMIC COGNITIVE DYSFUNCTION IN TYPE 1 DIABETES 78
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 76
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 76
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 74
Nocturnal blood glucose control in type I diabetes mellitus. 73
Early improvement of glucose tolerance after ileal transposition in a nonobese Type 2 diabetes rat model. 72
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia 70
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 70
Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents 70
18. Insulin required for prandial ghrelin suppression in humans 69
Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes 69
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 68
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 67
Adrenergic mechanisms do not contribute to glucose counterregulation during acute insulin-induced hypoglycaemia in normal man. 67
Physical activity habits and well-being among 6-year-old children: The “improving umbrian kids’ healthy lifestyle”, an uncontrolled pilot study project 67
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 66
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity 66
Cognitive function in hypoglycaemia 65
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 65
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 64
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 64
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 62
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 62
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 61
Counterregulatory responses in CSII 60
Ipoglicemia: cause e prevenzione 60
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 60
Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. 60
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans. 60
Premeal Insulin Treatment During Basal-Bolus Regimen in Young Children With Type 1 Diabetes 60
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 59
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 58
A novel surrogate index for hepatic insulin resistance. 58
Physical activity level and mediterranean diet adherence evaluation in older people - observational, uncontrolled, pilot study 58
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 57
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 57
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 57
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. 55
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 55
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 53
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 53
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus 53
Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. 53
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 53
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 53
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 52
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 51
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 51
Insulin is required for prandial ghrelin suppression in humans 51
null 49
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 49
Glucagon: the effects of its excess and deficiency on insulin action 49
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 49
Responses to hypoglycemia in diabetic autonomic neuropathy. 49
Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. 48
Effects of a supervised nordic walking program on obese adults with and without type 2 diabetes: The C.U.R.I.A.Mo. Centre experience 48
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 47
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 47
Sertoli cell-induced reversal of adult rat pancreatic islet beta-cells into fetal-like status: potential implications for islet transplantation in type I diabetes mellitus 46
Evaluation of maximum oxygen consumption in obese adolescents before and after a multidisciplinary lifestyle intervention 46
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 45
Insulin therapy and hypoglycemia: the size of the problem 45
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 45
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 45
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 45
Is physical activity a necessary element during Italian coronavirus disease emergency? Yes or no debate 45
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 44
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning 44
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 44
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. 44
La terapia insulinica nel diabete mellito tipo 2. 44
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 44
Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes 44
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 43
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 43
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 43
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM. 42
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 41
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 41
Contribution of cortisol to glucose counterregulation in humans 41
Diabete ­e ­cancro. 41
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 41
Recovery and prevention of hypoglycaemia unawareness in Type 1 diabetes mellitus 41
Are three months multidisciplinary lifestyle intervention enough to get benefits on blood pressure in overweight/obese adults ? 41
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 40
Late post-prandial hypoglycaemia as the sole presenting feature of secreting pancreatic beta-cell adenoma in a subtotally gastrectomized patient. 40
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 40
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 40
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 40
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 40
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 39
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes mellitus. 38
Totale 5.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020330 0 0 0 0 0 34 87 10 98 46 15 40
2020/20211.297 5 97 69 85 383 115 78 15 172 58 103 117
2021/20221.282 29 233 30 83 34 20 20 407 16 32 137 241
2022/20232.310 184 465 31 191 170 287 5 95 788 3 67 24
2023/2024999 54 105 43 33 8 8 205 14 81 39 187 222
2024/2025898 36 232 81 126 367 56 0 0 0 0 0 0
Totale 7.930